skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Pharmacoeconomics remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States
Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States

Guy, Holly ; Walder, Lydia ; Fisher, Mark

PharmacoEconomics, 2019-03, Vol.37 (3), p.391-405 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
2
Cost-Effectiveness Analysis of Triple Therapy with Protease Inhibitors in Treatment-Naive Hepatitis C Patients
Cost-Effectiveness Analysis of Triple Therapy with Protease Inhibitors in Treatment-Naive Hepatitis C Patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cost-Effectiveness Analysis of Triple Therapy with Protease Inhibitors in Treatment-Naive Hepatitis C Patients

Blázquez-Pérez, Antonio ; San Miguel, Ramón ; Mar, Javier

PharmacoEconomics, 2013-10, Vol.31 (10), p.919-931 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
3
Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and Extrapolation
Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and Extrapolation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and Extrapolation

Gibson, Eddie ; Koblbauer, Ian ; Begum, Najida ; Dranitsaris, George ; Liew, Danny ; McEwan, Phil ; Tahami Monfared, Amir Abbas ; Yuan, Yong ; Juarez-Garcia, Ariadna ; Tyas, David ; Lees, Michael

PharmacoEconomics, 2017-12, Vol.35 (12), p.1257-1270 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
4
A Q-TWiST Analysis Comparing Nivolumab and Therapy of Investigator’s Choice in Patients with Recurrent/Metastatic Platinum-Refractory Squamous Cell Carcinoma of the Head and Neck
A Q-TWiST Analysis Comparing Nivolumab and Therapy of Investigator’s Choice in Patients with Recurrent/Metastatic Platinum-Refractory Squamous Cell Carcinoma of the Head and Neck
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Q-TWiST Analysis Comparing Nivolumab and Therapy of Investigator’s Choice in Patients with Recurrent/Metastatic Platinum-Refractory Squamous Cell Carcinoma of the Head and Neck

Cocks, Kim ; Contente, Marta ; Simpson, Sarah ; DeRosa, Michael ; Taylor, Fiona C. ; Shaw, James W.

PharmacoEconomics, 2019-08, Vol.37 (8), p.1041-1047 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
5
Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and Recommendations
Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and Recommendations
Material Type:
Artigo 		Adicionar ao Meu Espaço

Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and Recommendations

van der Schans, Simon ; Goossens, Lucas M. A. ; Boland, Melinde R. S. ; Kocks, Janwillem W. H. ; Postma, Maarten J. ; van Boven, Job F. M. ; Rutten-van Mölken, Maureen P. M. H.

PharmacoEconomics, 2017-01, Vol.35 (1), p.43-63 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
6
The Clinical and Cost Effectiveness of Aflibercept in Combination with Irinotecan and Fluorouracil-Based Therapy (FOLFIRI) for the Treatment of Metastatic Colorectal Cancer Which has Progressed Following Prior Oxaliplatin-Based Chemotherapy: a Critique of the Evidence
The Clinical and Cost Effectiveness of Aflibercept in Combination with Irinotecan and Fluorouracil-Based Therapy (FOLFIRI) for the Treatment of Metastatic Colorectal Cancer Which has Progressed Following Prior Oxaliplatin-Based Chemotherapy: a Critique of the Evidence
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Clinical and Cost Effectiveness of Aflibercept in Combination with Irinotecan and Fluorouracil-Based Therapy (FOLFIRI) for the Treatment of Metastatic Colorectal Cancer Which has Progressed Following Prior Oxaliplatin-Based Chemotherapy: a Critique of the Evidence

Wade, Ros ; Duarte, Ana ; Simmonds, Mark ; Rodriguez-Lopez, Rocio ; Duffy, Steven ; Woolacott, Nerys ; Spackman, Eldon

PharmacoEconomics, 2015-05, Vol.33 (5), p.457-466 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
7
Biosimilars: How Can Payers Get Long-Term Savings?
Biosimilars: How Can Payers Get Long-Term Savings?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Biosimilars: How Can Payers Get Long-Term Savings?

Mestre-Ferrandiz, Jorge ; Towse, Adrian ; Berdud, Mikel

PharmacoEconomics, 2016-06, Vol.34 (6), p.609-616 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
8
Pertuzumab for the Neoadjuvant Treatment of Early-Stage HER2-Positive Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Pertuzumab for the Neoadjuvant Treatment of Early-Stage HER2-Positive Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pertuzumab for the Neoadjuvant Treatment of Early-Stage HER2-Positive Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Squires, Hazel ; Pandor, Abdullah ; Thokala, Praveen ; Stevens, John W. ; Kaltenthaler, Eva ; Clowes, Mark ; Coleman, Robert ; Wyld, Lynda

PharmacoEconomics, 2018, Vol.36 (1), p.29-38 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
9
Is Reclassification of the Oral Contraceptive Pill from Prescription to Pharmacist-Only Cost Effective? Application of an Economic Evaluation Approach to Regulatory Decisions
Is Reclassification of the Oral Contraceptive Pill from Prescription to Pharmacist-Only Cost Effective? Application of an Economic Evaluation Approach to Regulatory Decisions
Material Type:
Artigo 		Adicionar ao Meu Espaço

Is Reclassification of the Oral Contraceptive Pill from Prescription to Pharmacist-Only Cost Effective? Application of an Economic Evaluation Approach to Regulatory Decisions

Gumbie, Mutsa ; Parkinson, Bonny ; Cutler, Henry ; Gauld, Natalie ; Mumford, Virginia

PharmacoEconomics, 2019-08, Vol.37 (8), p.1049-1064 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
10
The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018)
The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018)
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018)

Greenberg, Paul E. ; Fournier, Andree-Anne ; Sisitsky, Tammy ; Simes, Mark ; Berman, Richard ; Koenigsberg, Sarah H. ; Kessler, Ronald C.

PharmacoEconomics, 2021-06, Vol.39 (6), p.653-665 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de1999  (50)
  2. 1999Até2004  (92)
  3. 2005Até2010  (303)
  4. 2011Até2017  (674)
  5. Após 2017  (733)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.